Proton pump inhibitor indications in a Brazilian tertiary hospital

• Autor(a) principal: Matoso,Abadia Gilda Buso
• Data de Publicação: 2020
• Outros Autores: Almeida,Fernanda Arantes Mendonça Toledo, Paiva,Lígia, Margonari,Patrícia Munhoz, Bertolin,Tainá Mendes, Sousa,Alisson Alves, Carvalho,Ana Júlia Araújo de, Alves,Ana Vera Cardoso, Santos,Ébony Lima dos, Teodoro,Lívia Lara, Silva,Thiago Trajano da
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Revista da Associação Médica Brasileira (Online)
• Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302020000700913
• topic: Proton pump inhibitors; Gastrointestinal hemorrhage/prevention & control; Therapeutic uses

SUMMARY OBJECTIVES To evaluate the frequency of prescription of proton pump inhibitors (PPIs) and their indications in patients hospitalized at the Hospital de Clínicas of the Federal University of Uberlândia (HC-UFU). METHODS This is a quantitative cross-sectional observational study that analyzes data obtained from patient records on prescriptions of PPIs for patients hospitalized at the HC-UFU and from a questionnaire applied to assistant physicians on the indications of the drug in each case and evaluates the indication based on literature data. RESULTS On a pre-determined day, of a total of 462 inpatients, there was a prescription of PPI for 183 (39.3%), with a higher frequency (73.5%) in the Intensive Care Unit (ICU), followed by the infirmaries and the Emergency Room. The assistant physician was located in 116 cases, and the main motivation referred to prescription was prophylaxis of digestive hemorrhage (77%). However, after reviewing medical records, it was noticed that in 50.8% of the cases, the prescription was not supported by the literature. CONCLUSION The frequency of PPI prescriptions for inpatients in the HC-UFU is among the lowest described in the literature, but there are still unnecessary prescriptions. Instruction and awareness of the assisting team can minimize these numbers.